secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001079973-25-000550
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc reports FY2024 net loss of $1.05M on revenue down 8% to $8.54M
----------------------------------------------------------------------

- Net loss of $1.053M ($0.41 diluted EPS) vs net profit of $205.6K ($0.08 EPS) in 2023.
- Revenue declined 8% to $8.538M from $9.330M; gross margin fell to 40.4% from 43.3%.
- Record R&D investment in SpinDx drug detection; beta testing of THC disk in Q2 2025, commercial launch early 2026.
- Closed $750K debenture in Dec 2024 plus $75K in Q1 2025 to fund SpinDx development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325000550/0001079973-25-000550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325000550/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-000550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer